Hexagon Bio
Latest round
- Series C
Last raised
- Oct 2026
Total raised
- $237M
Investors
- 11
About Hexagon Bio
Based in Menlo Park, California, Hexagon Bio, Inc. focuses on pioneering therapies primarily in oncology.Hexagon Bio, Inc. focuses on the discovery and development of innovative medicines, particularly next-generation antibody drug conjugates (ADCs) aimed at treating cancer. The company's core product offerings leverage advanced computational and chemical technologies to identify ADC payloads that possess novel mechanisms distinct from existing therapies. This strategic approach targets patient populations with significant unmet medical needs, enhancing treatment options for various cancer types. Hexagon Bio’s services cater to biopharmaceutical companies and healthcare providers globally, emphasizing markets across North America, Europe, and Asia.Hexagon Bio generates revenue through partnerships and collaborations with biopharmaceutical companies, leveraging their unique product offerings in the ADC space. These transactions typically involve collaborative research and development agreements, where Hexagon provides its advanced payloads to partners for further clinical development in specific oncology applications. Revenue streams may include milestone payments upon achieving developmental benchmarks and royalties on future sales of products derived from these collaborations.In September 2022, Hexagon Bio, Inc. The company plans to enhance its product pipeline and explore new therapeutic avenues, targeting additional markets in North America, Europe, and parts of Asia by the end of 2024.
Who invested in Hexagon Bio
11 investors across 4 rounds
See all investors in Hexagon Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hexagon Bio
Who invested in Hexagon Bio?
Hexagon Bio has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hexagon Bio raised?
Hexagon Bio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Hexagon Bio last raise money?
Hexagon Bio's most recent round on record is a Series C, in Oct 2026.
What does Hexagon Bio do?
Based in Menlo Park, California, Hexagon Bio, Inc.
Where is Hexagon Bio headquartered?
Hexagon Bio is headquartered in Menlo Park, US.
Which VCs invest in companies like Hexagon Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hexagon Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Hexagon Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.